Baskin Financial Services Inc. Point Biopharma Global Inc. Transaction History

Baskin Financial Services Inc.

  • $1.22 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 26, 2023
SELL
$6.86 - $10.86 $72,030 - $114,030
-10,500 Reduced 7.32%
132,990 $1.21 Million
Q3 2022

Oct 19, 2022
SELL
$7.24 - $10.31 $259,713 - $369,840
-35,872 Reduced 20.0%
143,490 $1.11 Million
Q4 2021

Jan 24, 2022
BUY
$4.83 - $9.75 $866,318 - $1.75 Million
179,362 New
179,362 $1 Million

Others Institutions Holding PNT

# of Institutions
1
Shares Held
20K
Call Options Held
0
Put Options Held
0
View Full List

About POINT Biopharma Global Inc.

PNT Quotes by TradingView
  • Ticker PNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,025,000
  • Description
  • POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...
More about PNT
Track This Portfolio

Track Baskin Financial Services Inc. Portfolio

Follow Baskin Financial Services Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baskin Financial Services Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baskin Financial Services Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email